Filtered By:
Specialty: Rheumatology
Condition: Rheumatoid Arthritis

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 161 results found since Jan 2013.

Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Conclusion. Despite achieving clinical remission, many RA patients do not achieve complete remission of their fatigue. Therefore, despite being important in overall disease control, reductions in disease activity are not always sufficient to ameliorate fatigue, so other symptom-specific management approaches must be considered for those for whom fatigue does not resolve.
Source: Rheumatology - September 22, 2016 Category: Rheumatology Authors: Druce, K. L., Bhattacharya, Y., Jones, G. T., Macfarlane, G. J., Basu, N. Tags: Rheumatoid Arthritis CLINICAL SCIENCE Source Type: research

Risk-benefit profile of statin therapy 'may be more positive than expected'
This study showed that providing an effective low-cost statin therapy to 10,000 patients for five years would prevent major cardiovascular events such as heart attacks, strokes and coronary artery bypasses in 1,000 people with preexisting vascular disease, as well as 500 people who are at increased risk but have not yet had a vascular event. By contrast, only 50 to 100 cases of symptomatic adverse events would be expected over the same period, as well as 50 to 100 new cases of diabetes, five cases of myopathy and between five and ten haemorrhagic strokes. Should statins be more widely used? Currently, about six million peo...
Source: Arthritis Research UK - September 8, 2016 Category: Rheumatology Source Type: news

Fatigue in rheumatoid arthritis 'may need to be treated separately'
This study highlights the need for better treatments for fatigue, which can be used alongside existing medication. We need to ensure fatigue has recognition from medical professionals so people can get the care they require."Along with pain, fatigue is one of the things that people with arthritis tell us has the biggest impact on their lives, which is why Arthritis Research UK is funding research into coping with the effects of fatigue on a day-to-day basis."
Source: Arthritis Research UK - June 23, 2016 Category: Rheumatology Source Type: news

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
ConclusionExposure to TNFi does not appear to influence the occurrence of ischemic stroke in the medium term in patients with RA. The impact on mortality after ischemic stroke remains inconclusive.
Source: Arthritis and Rheumatism - May 25, 2016 Category: Rheumatology Authors: Audrey S. L. Low, Mark Lunt, Louise K. Mercer, Kath D. Watson, William G. Dixon, Deborah P. M. Symmons, Kimme L. Hyrich Tags: Rheumatoid Arthritis Source Type: research

Rheumatoid Factors Are Associated with Subclinical and Clinical Atherosclerosis in African American Women: The Multi‐Ethnic Study of Atherosclerosis (MESA)
Conclusion. RA‐related autoantibodies are associated with subclinical and clinical atherosclerosis in AA women from a community based non‐RA cohort indicating autoimmune factors may play a role in the pathogenesis of atherosclerosis. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - May 8, 2016 Category: Rheumatology Authors: Darcy S. Majka, Thanh‐Huyen T. Vu, Richard M. Pope, Marius Teodorescu, Elizabeth W. Karlson, Kiang Liu, Rowland W. Chang Tags: Original Article Source Type: research

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration
Conclusions In this predominantly older male RA cohort, there was no clear association between LDL-C and CHD, whereas higher HDL-C was inversely associated with MI and stroke. CRP and ESR were similarly associated with increase MI risk and stroke, reflecting the prominent role of inflammation in CHD risk in RA.
Source: Annals of the Rheumatic Diseases - January 11, 2016 Category: Rheumatology Authors: Navarro-Millan, I., Yang, S., DuVall, S. L., Chen, L., Baddley, J., Cannon, G. W., Delzell, E. S., Zhang, J., Safford, M. M., Patkar, N. M., Mikuls, T. R., Singh, J. A., Curtis, J. R. Tags: Open access, Immunology (including allergy), Inflammation, Connective tissue disease, Degenerative joint disease, Musculoskeletal syndromes, Rheumatoid arthritis Clinical and epidemiological research Source Type: research

Association between ischaemic stroke and tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis
Conclusions: Exposure to TNFi does not appear to influence the occurrence of IS in the medium term in patients with RA. The impact on post‐IS mortality remains inconclusive. This article is protected by copyright. All rights reserved.
Source: Arthritis and Rheumatism - January 8, 2016 Category: Rheumatology Authors: Audrey S.L. Low, Mark Lunt, Louise K. Mercer, Kath D. Watson, William G. Dixon, Deborah P.M. Symmons, Kimme L. Hyrich Tags: Full Length Source Type: research

The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome
Abstract Patients with inflammatory rheumatic diseases (IRD) have a high burden of cardiovascular disease (CVD), leading to increased mortality and morbidity. However, it is not clear whether increased CVD mortality in IRD is due to a higher incidence or worse outcome of cardiovascular events (higher case fatality). In this observational case–control study, we assessed the outcome of acute coronary syndrome (ACS) in patients with IRDs compared to matched controls without IRD, using data from the Acute Coronary Syndrome Israeli Survey (ACSIS), a large, national, real-life registry detailing the extent, severity,...
Source: Clinical Rheumatology - January 1, 2016 Category: Rheumatology Source Type: research

Rheumatoid Arthritis, Anti–Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative
ConclusionAmong postmenopausal women, RA was associated with 1.5–2.5‐fold higher CVD risk. CVD risk was strongly associated with CVD risk factors, joint pain severity, and inflammation, but not with anti‐CCP positivity or RF positivity.
Source: Arthritis and Rheumatism - August 26, 2015 Category: Rheumatology Authors: Rachel H. Mackey, Lewis H. Kuller, Kevin D. Deane, Brian T. Walitt, Yue‐Fang Chang, V. Michael Holers, William H. Robinson, Russell P. Tracy, Mark A. Hlatky, Charles B. Eaton, Simin Liu, Matthew S. Freiberg, Mehret Birru Talabi, Erik B. Schelbert, Larry Tags: Rheumatoid Arthritis Source Type: research

Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry
The objective of this study is to examine the possibility of a relationship between subcutaneous nodules and “first ever” cardiovascular disease event, i.e., myocardial infarction (MI), stroke, or cardiovascular death in a large registry-cohort of patients with RA. Patient information was collected from the CORRONA registry from October 2001 to September 2011. A total of 26,042 patients with RA were studied for the presence or absence of subcutaneous nodules. Cox proportional hazards regression models were constructed to estimate the hazard ratios (HR) for CVD events in relation to subcutaneous nodules at baseline. Thr...
Source: Clinical Rheumatology - August 4, 2015 Category: Rheumatology Source Type: research

Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis.
CONCLUSION: Genetic variants of the NLRP3 inflammasome influence the risk of stroke/TIA, but not of MI/angina pectoris in Swedish patients with established RA. PMID: 26178285 [PubMed - as supplied by publisher]
Source: J Rheumatol - July 15, 2015 Category: Rheumatology Authors: Kastbom A, Ärlestig L, Rantapää-Dahlqvist S Tags: J Rheumatol Source Type: research

Epigenetic Aspects of Systemic Lupus Erythematosus
Abstract Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, autoimmune hepatitis, and inflammatory bowel disease have complex pathogeneses and the courses of events leading to these diseases are not well understood. The immune surveillance is a delicate balance between self and foreign as well as between tolerance and immune response. Exposure to certain environmental factors may impair this equilibrium, leading to autoimmune diseases, cancer, and the so-called “lifestyle diseases” such as atherosclerosis, heart attack, stroke, and obesity, among others. T...
Source: Rheumatology and Therapy - June 15, 2015 Category: Rheumatology Source Type: research

Rheumatoid arthritis: Link between RA and cardiovascular disease risk
Nature Reviews Rheumatology 11, 382 (2015). doi:10.1038/nrrheum.2015.77 Data from >160,000 postmenopausal women included in the Women's Health Initiative indicate that women with RA are at 1.5–2.5-fold higher risk of cardiovascular disease (CVD) morbidity and mortality over 10 years compared with women without RA (outcomes assessed included coronary heart disease, stroke, CVD, fatal
Source: Nature Reviews Rheumatology - June 2, 2015 Category: Rheumatology Tags: Research Highlight Source Type: research

Rheumatoid arthritis, anti‐CCP positivity, and cardiovascular disease risk in the Women's Health Initiative
Conclusion: Among postmenopausal women, RA was associated with 1.5‐2.5 higher CVD risk, strongly associated with CV risk factors, joint pain severity, and inflammation, but similar for anti‐CCP+ and RF+. This article is protected by copyright. All rights reserved.
Source: Arthritis and Rheumatism - May 18, 2015 Category: Rheumatology Authors: Rachel H. Mackey, Lewis H. Kuller, Kevin D. Deane, Brian T. Walitt, Yuefang F. Chang, V. Michael Holers, William H. Robinson, Russell P. Tracy, Mark A. Hlatky, Charles Eaton, Simin Liu, Matthew S. Freiberg, Mehret Birru Talabi, Erik B. Schelbert, Larry W. Tags: Full Length Source Type: research

Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis
Abstract Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been demonstrated to increase ischemic stroke risk, but the data on polymyositis (PM) and dermatomyositis (DM) remain unclear. We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio or standardized incidence ratio comparing ischemic risk in patients with PM/DM versus non-PM/DM participants. Pooled risk ratio and 95 % confidence intervals were calculated using a random-effect, generic inverse variance method of DerSimonian a...
Source: Rheumatology International - April 23, 2015 Category: Rheumatology Source Type: research